Lotus Leaf, Nuciferine, and Weight Management

    Lotus leaves from Nelumbo nucifera have long been used as both food and traditional medicine in Asia. The lotus leaf has been consumed in China for about 1,000 years as a natural remedy for weight management and reducing body fat, and it is still commonly used today as a tea or dietary supplement. Lotus leaves contain several bioactive compounds, mainly flavonoids and alkaloids. Important flavonoids include quercetin, isoquercetin, and kaempferol, while major alkaloids include nuciferine and related compounds. These compounds are believed to contribute to the plant’s antioxidant, anti-inflammatory, cardiovascular, and potential anti-obesity effects.

    Obesity is a growing global health concern linked to diabetes, fatty liver disease, hypertension, cardiovascular disease, sleep apnea, kidney disease, and chronic inflammation. Because many weight-loss medications have limited long-term effectiveness or may cause unwanted side effects, researchers are increasingly studying natural compounds from traditional foods and medicinal plants that may support metabolic health with relatively low toxicity. Nuciferine, one of the major alkaloids found in lotus leaves, has attracted particular attention for its potential effects on fat metabolism, inflammation, gut health, and obesity-related conditions (1).

    One animal study investigated the anti-obesity effects of lotus leaf extracts in mice fed a high-fat diet. The researchers found that lotus leaf extracts reduced body weight gain, decreased fat accumulation, and improved liver health. Blood levels of liver enzymes ALT, AST, and AKP were lowered, suggesting reduced liver damage. The extracts also improved blood lipid profiles by lowering total cholesterol, triglycerides, and LDL (“bad”) cholesterol while increasing HDL (“good”) cholesterol (2).

    The study further showed that lotus leaf extracts reduced obesity-related inflammation. Treatment lowered inflammatory cytokines including IL-1β, TNF-α, IFN-γ, and IL-6 while increasing anti-inflammatory cytokines IL-4 and IL-10. Gene analysis suggested that lotus leaf extracts may also influence fat metabolism by increasing expression of genes associated with fat burning and cholesterol breakdown, including PPAR-α, LPL, CPT1, and CYP7A1, while reducing genes linked to fat storage and fat cell formation, such as PPAR-γ and C/EBP-α. These findings suggest that lotus leaf extracts may help regulate lipid metabolism, inflammation, and fat accumulation through multiple metabolic pathways (2).

    Another study explored how nuciferine may affect obesity-related intestinal permeability, autophagy, and gut microbiota in mice fed a high-fat diet for eight weeks. Nuciferine supplementation reduced weight gain, fat accumulation, and intestinal permeability while improving autophagy, the body’s cellular cleanup and recycling process that helps remove damaged cellular material and maintain healthy cell function (3).

    Researchers also conducted laboratory experiments using Caco-2 and HT-29 intestinal cells. Nuciferine promoted the formation of autophagosomes and autophagolysosomes and helped protect intestinal barrier integrity against damage caused by lipopolysaccharide (LPS), a bacterial toxin associated with inflammation. Even after silencing the autophagy-related gene Atg5, nuciferine continued to reduce LPS-induced intestinal barrier damage, suggesting a strong protective effect on gut integrity through autophagy-related mechanisms (3).

    In addition, nuciferine altered gut microbiota composition by reducing Butyricimonas while increasing Akkermansia, a bacterium commonly associated with improved metabolic health and anti-obesity effects. Overall, the findings suggest that nuciferine may help reduce obesity-related intestinal permeability and inflammation partly through improvements in autophagy and gut microbiota balance (3).

    Another high-fat diet rat study also reported beneficial metabolic effects of nuciferine supplementation. Nuciferine helped prevent weight gain, reduce fat accumulation, and improve abnormal lipid metabolism caused by the high-fat diet. Gut microbiota analysis showed that nuciferine altered both the diversity and composition of intestinal bacteria (4).

    Notably, nuciferine reduced the Firmicutes-to-Bacteroidetes ratio, a gut microbiota pattern commonly associated with obesity. It also lowered the abundance of Desulfovibrio, a bacterium linked to LPS production and inflammation, while increasing beneficial short-chain fatty acid (SCFA)-producing bacteria (4). SCFAs are compounds produced by gut bacteria that help support gut barrier integrity, metabolism, and inflammation control.

    Further analysis suggested that nuciferine influenced microbial pathways involved in LPS production and lipid metabolism, while blood metabolomics analysis showed improvements in lipid metabolism disorders caused by the high-fat diet. Nuciferine also increased SCFA production and strengthened intestinal barrier integrity, helping reduce leakage of inflammatory bacterial toxins such as LPS into the bloodstream. This reduction in endotoxemia may help lower chronic low-grade inflammation associated with obesity and metabolic disease (4).

    Another study investigated the effects of lotus leaf ethanol extract in obese rats over a five-month period. The extract significantly lowered serum total cholesterol, triglycerides, and LDL cholesterol levels while reducing fat accumulation in the liver. It also improved inflammatory status by lowering IL-6 and TNF-α and increasing the anti-inflammatory cytokine IL-10 (5).

    In addition, lotus leaf ethanol extract favorably altered gut microbiota composition by increasing beneficial Muribaculaceae and reducing pro-inflammatory Firmicutes. The extract also regulated the abundance of Ruminococcus, which may contribute to improvements in lipid metabolism and reduced risk of hyperlipidemia. These findings suggest that lotus leaf ethanol extract may help improve obesity and fatty liver associated with a high-fat diet partly through modulation of gut microbiota and inflammation (5).

    Current research suggests that lotus leaf and its bioactive compounds, particularly nuciferine, quercetin, isoquercetin, and kaempferol, may support weight management through multiple mechanisms. Animal and laboratory studies show potential benefits for reducing fat accumulation, improving blood lipid profiles, supporting liver health, lowering inflammation, strengthening intestinal barrier integrity, enhancing autophagy, and improving gut microbiota balance. While most evidence so far comes from preclinical studies, these findings support the potential of lotus leaf as a promising functional food ingredient or natural compound for metabolic health and obesity support.

References:

1.         Wan Y, Xia J, Xu JF, Chen L, Yang Y, Wu JJ, Tang F, Ao H, Peng C. Nuciferine, an active ingredient derived from lotus leaf, lights up the way for the potential treatment of obesity and obesity-related diseases. Pharmacol Res. 2022 Jan;175:106002. doi: 10.1016/j.phrs.2021.106002. Epub 2021 Nov 24. PMID: 34826599.

2.          Wu, Y., Tan, F., Zhang, T. et al. The anti-obesity effect of lotus leaves on high-fat-diet-induced obesity by modulating lipid metabolism in C57BL/6J mice. Appl Biol Chem 63, 61 (2020). https://doi.org/10.1186/s13765-020-00541-x

3.         Shi Z, Fang ZY, Gao XX, Yu H, Zhu YW, Ouyang HL, Song YX, Du XL, Wang Z, Li XW, Liu GW. Nuciferine improves high-fat diet-induced obesity via reducing intestinal permeability by increasing autophagy and remodeling the gut microbiota. Food Funct. 2021 Jul 5;12(13):5850-5861. doi: 10.1039/d1fo00367d. PMID: 34018523.

4.         Wang Y, Yao W, Li B, Qian S, Wei B, Gong S, Wang J, Liu M, Wei M. Nuciferine modulates the gut microbiota and prevents obesity in high-fat diet-fed rats. Exp Mol Med. 2020 Dec;52(12):1959-1975. doi: 10.1038/s12276-020-00534-2. Epub 2020 Dec 1. PMID: 33262480; PMCID: PMC8080667.

5.         Yanan Z, Lu M, Lu Z, Jinhai H, Weiming W. Effects and action mechanisms of lotus leaf (Nelumbo nucifera) ethanol extract on gut microbes and obesity in high-fat diet-fed rats. Front Nutr. 2023 Jun 26;10:1169843. doi: 10.3389/fnut.2023.1169843. PMID: 37435567; PMCID: PMC10332267.

The image is produced by ChatGPT